Deconstructing Vancomycin

See allHide authors and affiliations

Science  16 Apr 1999:
Vol. 284, Issue 5413, pp. 442-443
DOI: 10.1126/science.284.5413.442

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The glycopeptide antibiotic vancomycin is a drug of last resort for treating Gram-positive bacterial infections that do not respond to other antibiotics. But there have been recent reports of multi�drug-resistant bacteria that are even resistant to vancomycin. Ge et al. now report the synthesis of vancomycin analogs that are more powerful than the parent compound in killing both vancomycin-sensitive and vancomycin-resistant Gram-positive bacteria. In a Perspective, Walsh explains how the new analogs kill bacteria by blocking a different step in the pathway of bacterial cell wall synthesis. These findings suggest that simple sugar fragments may form a new class of antibiotics.